Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Open Access
- 11 October 2019
- journal article
- review article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 190 (1), 2-10
- https://doi.org/10.1016/j.ajpath.2019.09.005
Abstract
No abstract availableKeywords
Funding Information
- Allergan
This publication has 84 references indexed in Scilit:
- The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challengesBriefings in Functional Genomics, 2013
- Cutaneous CD30‐positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 casesJournal of Cutaneous Pathology, 2012
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- A novel role for IL-22R1 as a driver of inflammationBlood, 2011
- JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted TherapiesGenes & Cancer, 2010
- Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferationsHaematologica, 2010
- Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T CellsScience, 2010
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphomaBlood, 2010
- Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphomaLeukemia, 2009
- The role of IL-6 and STAT3 in inflammation and cancerEuropean Journal of Cancer, 2005